The worldwide impact of telemedicine during COVID-19: current evidence and recommendations for the futureStefano Omboni, Ji‐Guang Wang, А. О. Конради et al.|Connected Health|2022Cited by 373
Lifestyle management of hypertension: International Society of Hypertension position paper endorsed by the World Hypertension League and European Society of HypertensionFadi J. Charchar, Maciej Tomaszewski, Priscilla R. Prestes et al.|Journal of Hypertension|2023Cited by 245
Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trialJordana B. Cohen, Julio A. Chirinos, Thomas C. Hanff et al.|The Lancet Respiratory Medicine|2021Cited by 224
Randomized elimination and prolongation of ACE inhibitors and ARBs in coronavirus 2019 (REPLACE COVID) Trial ProtocolJordana B. Cohen, Julio A. Chirinos, Thomas C. Hanff et al.|Journal of Clinical Hypertension|2020Cited by 19